Efficient extraction of virus DNA by NucliSens extractor allows sensitive detection of hepatitis B virus by PCR

被引:11
作者
Gobbers, E
Oosterlaken, TAM
van Bussel, MJAWM
Melsert, R
Kroes, ACM
Claas, ECJ
机构
[1] Organon Teknika BV, NL-5281 Boxtel, Netherlands
[2] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands
关键词
D O I
10.1128/JCM.39.12.4339-4343.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The NucliSens Extractor is an automated nucleic acid isolation system based on guanidinium thiocyanate (GuSCN)-silica extraction technology. The system has been validated for the isolation of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) RNAs from human samples in combination with nucleic acid sequence-based amplification- and reverse transcription-PCR-hased methods. We evaluated the extractor for hepatitis B virus (HBV) DNA extraction from human samples using a noncommercial HBV DNA PCR. Several sample pretreatment procedures in combination with the extractor were compared with the Qiagen extraction method, and the impact of the sample volume used in the extraction on the sensitivity was investigated. Heating of the lysed sample prior to extractor isolation and the use of a large sample volume resulted in highly sensitive detection of HBV DNA. Incubation of a 1-ml sample in GuSCN at 80 degreesC (10 min) and at 37 degreesC (30 min) allowed detection of 4 and 40 HBV genome equivalents/ml, respectively, in standard dilution panels. Sample lysis in GuSCN at room temperature and proteinase K treatment prior to use of the extractor were less efficient procedures. All clinical samples that were PCR positive after Qiagen extraction and/or that were HBsAg positive were also PCR positive after extractor isolation. HBV DNA, HCV RNA, and HIV type 1 RNA were efficiently coextracted from a single sample, allowing reliable detection of viral genomes.
引用
收藏
页码:4339 / 4343
页数:5
相关论文
共 24 条
[1]   Quantitation of hepatitis B virus genomic DNA by real-time detection PCR [J].
Abe, A ;
Inoue, K ;
Tanaka, T ;
Kato, J ;
Kajiyama, N ;
Kawaguchi, R ;
Tanaka, S ;
Yoshiba, M ;
Kohara, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (09) :2899-2903
[2]  
BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
[3]  
2-J
[4]   Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems [J].
Beld, M ;
Habibuw, MR ;
Rebers, SPH ;
Boom, R ;
Reesink, HW .
TRANSFUSION, 2000, 40 (05) :575-579
[5]   RAPID PURIFICATION OF HEPATITIS-B VIRUS-DNA FROM SERUM [J].
BOOM, R ;
SOL, CJA ;
HEIJTINK, R ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :1804-1811
[6]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[7]   Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening [J].
Cuijpers, HTM ;
Molijn, MHJ ;
Bos, HJ ;
Peeters, APW ;
van der Poel, CL ;
Lelie, PN .
VOX SANGUINIS, 2001, 81 (01) :12-20
[8]   European multi-centre validation study of NucliSens extractor in combination with HCV amplicor 2.0 assay for HCV-NAT screening of plasma pools [J].
Cuypers, HTM ;
van Dijk, R ;
Viret, JF ;
Schottstedt, V ;
Lankinen, M ;
Cardoso, MD ;
Lelie, PN .
BIOLOGICALS, 1999, 27 (04) :303-314
[9]   Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening [J].
Drosten, C ;
Weber, M ;
Seifried, E ;
Roth, WK .
TRANSFUSION, 2000, 40 (06) :718-724
[10]   HEPATITIS-B VIRUS CONTAINS PROTEIN ATTACHED TO THE 5' TERMINUS OF ITS COMPLETE DNA STRAND [J].
GERLICH, WH ;
ROBINSON, WS .
CELL, 1980, 21 (03) :801-809